Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2021 Filed Jul 16, 2021 21:00 UTC |
Evans Carl AnthonyDirector
|
GrantOption to purchase common stock · Derivative | 32,000 | Not disclosed Strike: $1.80 | Not disclosed |
DisclosureSEC source: 0001683168-21-002998 · ownership.xml · derivative · entry 1 Evans Carl Anthony · CIK 0001792582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,559 Underlying: Common Stock · 32,000 shares Expires 2031-07-15 F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company. F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the date hereof or the date of the 2022 annual meeting, subject to the grantee's continued service to the Company on the vesting date. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 22:00 UTC |
Downs Christopher SChief Financial Officer
|
GrantOption to purchase common stock (right to buy) · Derivative | 131,000 | Not disclosed Strike: $3.36 | Not disclosed |
DisclosureSEC source: 0001683168-21-000448 · ownership.xml · derivative · entry 1 Downs Christopher · CIK 0001705978 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431,000 Underlying: Common Stock · 131,000 shares Expires 2031-02-05 F2 · price: The stock options were issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock options set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date and are subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| February 05, 2021 Filed Feb 9, 2021 17:00 UTC |
Climaco John MDirector · Chief Executive Officer
|
GrantOption to purchase common stock (right to buy) · Derivative | 310,000 | Not disclosed Strike: $3.36 | Not disclosed |
DisclosureSEC source: 0001683168-21-000447 · ownership.xml · derivative · entry 1 Climaco John M · CIK 0001546797 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 749,500 Underlying: Common Stock · 310,000 shares Expires 2031-02-05 F2 · price: The stock options were issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock options set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date and are subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| August 24, 2020 Filed Aug 25, 2020 23:11 UTC |
Downs Christopher SChief Financial Officer
|
PurchaseCommon Stock | 142,000 | $2.04 | $289,680.00 |
DisclosureSEC source: 0001683168-20-002862 · ownership.xml · nonDerivative · entry 1 Downs Christopher · CIK 0001705978 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,000 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.84 to $2.30. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC |
Keyes Jeffry R.Director
|
GrantOption to purchase common stock · Derivative | 46,559 | Not disclosed Strike: $2.47 | Not disclosed |
DisclosureSEC source: 0001683168-20-001968 · ownership.xml · derivative · entry 1 Keyes Jeffry R. · CIK 0001557736 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,559 Underlying: Common Stock · 46,559 shares Expires 2030-06-12 F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company. F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC |
Evans Carl AnthonyDirector
|
GrantOption to purchase common stock · Derivative | 46,559 | Not disclosed Strike: $2.47 | Not disclosed |
DisclosureSEC source: 0001683168-20-001966 · ownership.xml · derivative · entry 1 Evans Carl Anthony · CIK 0001792582 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,559 Underlying: Common Stock · 46,559 shares Expires 2030-06-12 F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company. F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:23 UTC |
Gumulka JerzyDirector
|
GrantOption to purchase common stock · Derivative | 46,559 | Not disclosed Strike: $2.47 | Not disclosed |
DisclosureSEC source: 0001683168-20-001967 · ownership.xml · derivative · entry 1 Gumulka Jerzy · CIK 0001793252 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,559 Underlying: Common Stock · 46,559 shares Expires 2030-06-12 F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company. F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 21:22 UTC |
Andraczke AndrzejDirector
|
GrantOption to purchase common stock · Derivative | 46,559 | Not disclosed Strike: $2.47 | Not disclosed |
DisclosureSEC source: 0001683168-20-001965 · ownership.xml · derivative · entry 1 Andraczke Andrzej · CIK 0001792732 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,559 Underlying: Common Stock · 46,559 shares Expires 2030-06-12 F2 · price: The stock options were issued in connection with the reporting person's Board of Director services to the Company. F1 · derivative.exercise_date: The stock options set forth in this table vest on the earlier of the one-year anniversary of the issuance date or the date of the 2021 annual meeting, subject to the grantee's continued service to the Company on the vesting date. Read SEC document |
| May 05, 2020 Filed Jan 25, 2022 16:05 UTC |
Priebe Waldemar10% owner
|
OtherCommon Stock | 1,495,867 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-22-000460 · ownership.xml · nonDerivative · entry 1 Priebe Waldemar · CIK 0001678516 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,533,133 F1 · price: The shares are held by a limited liability company for which the reporting person's adult child is the sole manager and adult children are sole members. Prior to May 5, 2020, the reporting person was a manager of the limited liability company. The reporting person ceased to be a manager of the limited liability company on May 5, 2020, and since such date has not had any voting or dispositive power over the shares held by the limited liability company. The reporting person has never had a pecuniary interest in the limited liability company. F2 · ownership.nature: Consists of: (i) 7,333,133 shares of common stock held by a limited liability company; and (ii) 200,000 shares held by Houston Pharmaceuticals, Inc. Read SEC document |
| November 13, 2019 Filed Nov 13, 2019 22:12 UTC |
Downs Christopher SChief Financial Officer
|
GrantOption to purchase common stock (right to buy) · Derivative | 300,000 | Not disclosed Strike: $4.00 | Not disclosed |
DisclosureSEC source: 0001683168-19-003571 · ownership.xml · derivative · entry 1 Downs Christopher · CIK 0001705978 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2029-11-13 F2 · price: The stock options were issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock options set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date and are subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.